262 related articles for article (PubMed ID: 23303344)
1. Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.
Lavine JA; Sang Y; Wang S; Ip MS; Sheibani N
JAMA Ophthalmol; 2013 Mar; 131(3):376-82. PubMed ID: 23303344
[TBL] [Abstract][Full Text] [Related]
2. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
[TBL] [Abstract][Full Text] [Related]
3. Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization.
Omri S; Tahiri H; Pierre WC; Desjarlais M; Lahaie I; Loiselle SE; Rezende F; Lodygensky G; Hebert TE; Ong H; Chemtob S
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4632-4642. PubMed ID: 31682714
[TBL] [Abstract][Full Text] [Related]
4. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation.
Wang H; Han X; Wittchen ES; Hartnett ME
Mol Vis; 2016; 22():116-28. PubMed ID: 26900328
[TBL] [Abstract][Full Text] [Related]
5. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
6. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells.
Zhu J; Wang YS; Zhang J; Zhao W; Yang XM; Li X; Jiang TS; Yao LB
Exp Eye Res; 2009 May; 88(5):910-8. PubMed ID: 19111720
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
[TBL] [Abstract][Full Text] [Related]
10. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition.
Droho S; Cuda CM; Perlman H; Lavine JA
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5059-5069. PubMed ID: 31800964
[TBL] [Abstract][Full Text] [Related]
13. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization.
Yoshikawa N; Noda K; Ozawa Y; Tsubota K; Mashima Y; Ishida S
Mol Vis; 2012; 18():593-600. PubMed ID: 22419852
[TBL] [Abstract][Full Text] [Related]
14. Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization.
Takeuchi A; Takeuchi M; Oikawa K; Sonoda KH; Usui Y; Okunuki Y; Takeda A; Oshima Y; Yoshida K; Usui M; Goto H; Kuroda M
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3410-6. PubMed ID: 19182260
[TBL] [Abstract][Full Text] [Related]
15. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
[TBL] [Abstract][Full Text] [Related]
16. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
[TBL] [Abstract][Full Text] [Related]
17. Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration.
Wang H; Han X; Kunz E; Hartnett ME
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5525-5534. PubMed ID: 27768790
[TBL] [Abstract][Full Text] [Related]
18. Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization.
Sengupta N; Afzal A; Caballero S; Chang KH; Shaw LC; Pang JJ; Bond VC; Bhutto I; Baba T; Lutty GA; Grant MB
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2697-704. PubMed ID: 20007826
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
[TBL] [Abstract][Full Text] [Related]
20. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
